We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Guidance on Human Gene Therapy Products Incorporating Human Genome Editing
FDA Offers Guidance on Human Gene Therapy Products Incorporating Human Genome Editing
The FDA has advised sponsors of gene therapy products that incorporate human genome editing (GE) on how best to communicate with the FDA about products in development in a draft guidance released yesterday.